We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Psychedelics

This page provides educational resources, events, news and products related to psychedelics. Content will cover aspects from the impact of psychedelics on the brain to their therapeutic potential.

Psychedelics – Highlights

What Are the Key Psychedelic Drugs? content piece image

What Are the Key Psychedelic Drugs?

Interest in the therapeutic potential of psychedelics, having lain relatively dormant in the face of stigma and heavy regulations for decades, has reignited in the last ten years. In this infographic, we review five psychedelics, detailing their structure, mechanism of action and their potential clinical applications.

Antidepressant Psychedelics Could Be Separated From Hallucinations, Suggest Crystal Structure Researchers

Researchers find potentially non-hallucinatory psychedelic compounds by examining crystal structures.

Industry Insight

What Is the Best Approach to Psychedelic Therapy? An Interview With Field Trip’s Ronan Levy

We spoke to co-founder and executive chairman, Ronan Levy, to find out more about Field Trip’s approach to psychedelic therapy and why 2021 has been such a significant year in psychedelics.

The Neuroscience of Psychedelic Drugs: Your Brain on Psilocybin With Frederick Streeter Barrett

Fred Barrett is an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University in Baltimore. In this interview, we discuss his work with the active component of magic mushrooms, psilocybin. Fred explains how this compound affects the brain, its potential to combat visceral pain, and its links to so-called mystical experiences.

The Power of Placebo in Psychedelic Trials

Ketamine is increasingly used as an antidepressant. A new clinical trial suggests the drug's effects may be may be placebo-based. In this article, we explore what that means for the drug's rollout for ketamine and psychedelic research.

Psychedelics – News and Features

Ketamine Clinics Misleading Consumers About Side Effects, Suggests Study

An analysis of Maryland ketamine advertisers has suggested that their websites and marketing materials are awash with false and misleading claims about the drug’s addictiveness, side effects and approval status.

One All-Nighter Can Reverse Depression for Several Days

Most people who have pulled an all-nighter are too familiar with that “tired and wired” feeling. The body is physically exhausted, the brain feels loopy and almost giddy. Now, neurobiologists are the first to uncover what produces this effect.

The Pulse: Psychedelic News From Technology Networks Issue 7

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

Pain-Busting Ballads: Researchers Identify Music That Best Soothes Pain

Your favorite music might be good for more than a workout soundtrack or late-night listening session, suggests a new study. The research suggests that individuals’ most-loved music could reduce feelings of pain compared to relaxing stock music.

Why Is Ketamine Still Inaccessible for Those With Severe Depression?

Patients with treatment-resistant depression are missing out on potentially life-changing treatment with ketamine because systemic barriers in the public health system have made it unaffordable.

Mummified Poop Reveals Diet Choices of Pre-Columbian Cultures of the Caribbean

DNA analysis of mummified poop reveals two pre-Columbian Caribbean cultures ate a wide variety of plants, like maize, sweet potato, and peanuts—and tobacco and cotton traces were detected too, according to a study.

Psychedelics – Multimedia

Psychedelic shapes

The Profound Potential of DMT

LSD illustration

What LSD Does to the Brain

A woman wraps a man's leg with a bandage.

How To Hack Your Brain When You're in Pain

Psychedelics – Webinars and Online Events

Ask Me Anything: Psychedelics

The Neuroscience of Psychedelics – Harnessing Neuroplasticity for New Therapeutics

Ryan Pincura, Director of Regulatory Affairs, Tendrel Group

The Challenges of Psilocybin Legal Licensing and Compliance

Related Products

World's First Ketamine Treatment Study for a Range of Behavioral Addictions Completed content piece image

World's First Ketamine Treatment Study for a Range of Behavioral Addictions Completed

MAPS and Wesana Health Resume Final Negotiations

Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline

Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction

Origin Therapeutics Launches To Fund Emerging Psychedelics Companies

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter